Immunocore Holdings plc (IMCR)
USD 25.57
(-6.2%)
USD 25.57
(-6.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 248.39 Million USD | 73.36% |
| 2022 | 143.28 Million GBP | 406.78% |
| 2021 | -46.7 Million GBP | -4.5% |
| 2020 | -44.69 Million GBP | 39.86% |
| 2019 | -74.32 Million GBP | -414.2% |
| 2018 | 23.65 Million GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 73.69 Million USD | 4.89% |
| 2024 Q1 | 70.25 Million USD | -33.65% |
| 2023 Q3 | 62.35 Million USD | 5.04% |
| 2023 Q4 | 105.88 Million USD | 69.8% |
| 2023 FY | 248.39 Million USD | 73.36% |
| 2023 Q1 | 54.83 Million USD | 14.35% |
| 2023 Q2 | 59.36 Million USD | 8.26% |
| 2022 Q1 | 22.22 Million GBP | 237.12% |
| 2022 Q4 | 47.95 Million GBP | 16.57% |
| 2022 FY | 143.28 Million GBP | 406.78% |
| 2022 Q3 | 41.13 Million GBP | 28.68% |
| 2022 Q2 | 31.96 Million GBP | 43.83% |
| 2021 Q3 | 5.92 Million GBP | 3.33% |
| 2021 FY | -46.7 Million GBP | -4.5% |
| 2021 Q2 | 5.73 Million GBP | -30.68% |
| 2021 Q1 | 8.27 Million GBP | 11.46% |
| 2021 Q4 | 6.59 Million GBP | 11.29% |
| 2020 FY | -44.69 Million GBP | 39.86% |
| 2020 Q2 | 7.78 Million GBP | -5.67% |
| 2020 Q4 | 7.42 Million GBP | 11.55% |
| 2020 Q3 | 6.65 Million GBP | -14.58% |
| 2020 Q1 | 8.25 Million GBP | 46.31% |
| 2019 FY | -74.32 Million GBP | -414.2% |
| 2019 Q4 | 5.64 Million GBP | 0.0% |
| 2018 FY | 23.65 Million GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -553.231% |
| Alkermes plc | 1.37 Billion USD | 81.931% |
| Agenus Inc. | 139.61 Million USD | -77.911% |
| Aptorum Group Limited | -1.11 Million USD | 22383.455% |
| Ardelyx, Inc. | 106.66 Million USD | -132.879% |
| Dyadic International, Inc. | 922.95 Thousand USD | -26812.521% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1079.388% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 142165.167% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1959.514% |
| Novavax, Inc. | 639.93 Million USD | 61.185% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 630.308% |
| Pyxis Oncology, Inc. | -2 Million USD | 12519.55% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 48168.297% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1204.369% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 562223.201% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 47233.017% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 352.9% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -30871.446% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 303015.854% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -83.627% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -3055.774% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 356.205% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 83.636% |
| AlloVir, Inc. | -398 Thousand USD | 62509.799% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -3.18% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -58482.783% |
| Bicycle Therapeutics plc | -129.52 Million USD | 291.778% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -206892.5% |
| ChromaDex Corporation | 50.78 Million USD | -389.151% |
| Chimerix, Inc. | 324 Thousand USD | -76563.889% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 896.951% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 420.1% |
| CRISPR Therapeutics AG | 240.95 Million USD | -3.086% |
| Precision BioSciences, Inc. | 40.47 Million USD | -513.735% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 353.039% |
| Fortress Biotech, Inc. | 57.85 Million USD | -329.349% |
| Fortress Biotech, Inc. | 57.85 Million USD | -329.349% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1398.407% |
| ImmuCell Corporation | 4.39 Million USD | -5550.022% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 334.06% |
| Immix Biopharma, Inc. | -5468.00 USD | 4542729.846% |
| Incyte Corporation | 3.44 Billion USD | 92.781% |
| Innoviva, Inc. | 261.06 Million USD | 4.855% |
| IO Biotech, Inc. | -756 Thousand USD | 32955.952% |
| Jaguar Health, Inc. | 7.72 Million USD | -3115.834% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 37508.283% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -107.419% |
| ContextLogic Inc. | 59 Million USD | -321.002% |
| MiMedx Group, Inc. | 266.84 Million USD | 6.915% |
| MEI Pharma, Inc. | 49.32 Million USD | -403.56% |
| NextCure, Inc. | -3.68 Million USD | 6842.427% |
| Onconetix, Inc. | -1.12 Million USD | 22136.791% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 957.467% |
| Opthea Limited | 21.72 Thousand USD | -1143504.972% |
| Psyence Biomedical Ltd. | -240.00 USD | 103496350.0% |
| Vaxcyte, Inc. | -75 Million USD | 431.188% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 433395.538% |
| Precigen, Inc. | 106 Thousand USD | -234231.132% |
| Pharming Group N.V. | 220.1 Million USD | -12.852% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -48131.262% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -24517.542% |
| PureTech Health plc | -1.6 Million USD | 15595.384% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -126.279% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 236.924% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 648.022% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1229.718% |
| Acelyrin, Inc. | -115 Thousand USD | 216092.174% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2471406.338% |
| Summit Therapeutics Inc. | -2.05 Million USD | 12216.634% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 43601.051% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9357.958% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -6031.597% |
| Elevation Oncology, Inc. | -39 Thousand USD | 637000.0% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5276.97% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6401.065% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -752.728% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -49978.831% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 451720.0% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -138.61% |
| Seer, Inc. | 7.02 Million USD | -3434.809% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5573.618% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1052.894% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 209728.579% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 173435.148% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -40686.7% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -106.178% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 20.812% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4967920.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9550.0% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 489636.855% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -745.241% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 107165.086% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 50585.976% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3599.451% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 52442.981% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2388475.0% |
| Soligenix, Inc. | 97.31 Thousand USD | -255154.802% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2398.002% |
| Kura Oncology, Inc. | -849 Thousand USD | 29356.89% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 470.158% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 169073.469% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -150.801% |
| Autolus Therapeutics plc | -4.86 Million USD | 5203.575% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -500.181% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 147951.786% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -162.229% |
| GRI Bio, Inc. | 10.84 Million USD | -2191.219% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9679.227% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2959.342% |
| IGM Biosciences, Inc. | -211.66 Million USD | 217.354% |
| INmune Bio, Inc. | 155 Thousand USD | -160152.258% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -301.025% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16590.24% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 38405.107% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 848603.792% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -61688.806% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12544.439% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 79458.147% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -162.956% |
| Verastem, Inc. | -62 Thousand USD | 400730.645% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -10100.862% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 95268.966% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -8105.847% |
| Histogen Inc. | 3.76 Million USD | -6490.369% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -43010.04% |
| Surrozen, Inc. | -27.23 Million USD | 1012.196% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4709.222% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 20715.414% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1068.499% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1138.734% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12545100.0% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3994.522% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 370109.385% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -60.469% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -170264.198% |
| Apollomics, Inc. | 127 Thousand USD | -195483.465% |
| Amarin Corporation plc | 165.54 Million USD | -50.048% |
| Mesoblast Limited | -9.81 Million USD | 2630.728% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1404.853% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 324.811% |
| Synaptogenix, Inc. | -6347.00 USD | 3913618.198% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 487141.176% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -53.931% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 85.868% |
| Better Therapeutics, Inc. | -2.72 Million USD | 9201.905% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 321.459% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 26.529% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2177440.463% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 4067.907% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 22517.96% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3294.247% |
| Insmed Incorporated | 239.63 Million USD | -3.654% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6842.174% |
| OmniAb, Inc. | 14.66 Million USD | -1593.537% |
| Alector, Inc. | -95.05 Million USD | 361.318% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -97.73% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 671.5% |
| Zai Lab Limited | 170.9 Million USD | -45.34% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -203.371% |
| Aura Biosciences, Inc. | -1.29 Million USD | 19280.772% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -190970.0% |
| Immunic, Inc. | -111 Thousand USD | 223875.676% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1466.74% |
| Veracyte, Inc. | 248.14 Million USD | -0.098% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.554% |
| FibroGen, Inc. | 128.9 Million USD | -92.695% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 44041057.447% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2229.026% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.691% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -63753.728% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 30.099% |
| TG Therapeutics, Inc. | 219.1 Million USD | -13.365% |
| Galecto, Inc. | -830 Thousand USD | 30026.627% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 18034.368% |
| Fortrea Holdings Inc. | 424 Million USD | 41.417% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 388.267% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 43907.937% |
| XBiotech Inc. | -1.74 Million USD | 14342.603% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 22517.96% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 634.508% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 428.847% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -238.394% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1378.254% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 36.153% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 600.314% |
| Vaxxinity, Inc. | -2.23 Million USD | 11218.666% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 23.982% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2293.522% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -915.873% |
| NexImmune, Inc. | -1.02 Million USD | 24333.93% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4599733.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3595.68% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.802% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 371792.579% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 7094.959% |
| Ainos, Inc. | -253.73 Thousand USD | 97994.637% |
| Pluri Inc. | 322 Thousand USD | -77040.062% |
| Prothena Corporation plc | -129.2 Million USD | 292.252% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -392.605% |
| Celularity Inc. | 6.75 Million USD | -3577.143% |
| Rallybio Corporation | -150 Thousand USD | 165694.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 861.772% |
| MeiraGTx Holdings plc | 287 Thousand USD | -86447.387% |
| Omeros Corporation | -69.77 Million USD | 455.968% |
| Humacyte, Inc. | -76.55 Million USD | 424.482% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1737.491% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -298.177% |
| Blueprint Medicines Corporation | 236.58 Million USD | -4.991% |
| CalciMedica, Inc. | -58 Thousand USD | 428360.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 17518.724% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -754.899% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8833.861% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 904.766% |
| Pulmatrix, Inc. | -8.22 Million USD | 3121.788% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 21330.0% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 62353.383% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 162.286% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8849.14% |
| Cytokinetics, Incorporated | -322.59 Million USD | 176.998% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -28712.152% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 72941.935% |
| Vor Biopharma Inc. | -3.49 Million USD | 7213.144% |
| Roivant Sciences Ltd. | 109.23 Million USD | -127.391% |
| Evogene Ltd. | 1.39 Million USD | -17654.896% |
| ProKidney Corp. | -3.16 Million USD | 7938.151% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 665.656% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3522.444% |
| CorMedix Inc. | -205.56 Thousand USD | 120935.077% |
| BioLineRx Ltd. | 1.1 Million USD | -22317.96% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 415.734% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 752800.0% |
| Atai Life Sciences N.V. | -5000.00 USD | 4967920.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 203934.76% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 258840.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17982.721% |
| Sagimet Biosciences Inc. | 2 Million USD | -12319.55% |
| MediciNova, Inc. | 979.7 Thousand USD | -25253.652% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 394.585% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 262794.728% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1298.754% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -1.577% |
| Biomea Fusion, Inc. | -4.2 Million USD | 6012.664% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 71.526% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3244.883% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 80226.129% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2070025.0% |
| Absci Corporation | -41.84 Million USD | 693.541% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4967920.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 425.234% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 10193.092% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -16.214% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 26496.493% |
| Allakos Inc. | -6.14 Million USD | 4144.797% |
| Imunon, Inc. | -720 Thousand USD | 34598.51% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 460.008% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 47.805% |
| BioAtla, Inc. | -103.73 Million USD | 339.457% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2177440.463% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 139645.506% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 202.295% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 79968.489% |
| XOMA Corporation | 3.86 Million USD | -6333.333% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 454.414% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1578.998% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10501.633% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1893.507% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 856620.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | 24741.964% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1910699900.0% |
| Akari Therapeutics, Plc | -4000.00 USD | 6209875.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 61.0% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -127471.029% |
| UroGen Pharma Ltd. | 73.35 Million USD | -238.629% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1030.512% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2139357.364% |
| Orgenesis Inc. | -5.72 Million USD | 4438.707% |
| Entera Bio Ltd. | -56 Thousand USD | 443655.357% |
| GH Research PLC | -315 Thousand USD | 78954.286% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 131523.81% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 47412.571% |
| Xencor, Inc. | -85.26 Million USD | 391.334% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 112505.816% |
| Replimune Group, Inc. | -2.65 Million USD | 9455.593% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24908.437% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -39.668% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -127471.029% |
| Portage Biotech Inc. | -54 Thousand USD | 460083.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 262794.728% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 65986.207% |
| OncoCyte Corporation | 413 Thousand USD | -60043.099% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5526039.933% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 111887937.838% |
| Purple Biotech Ltd. | -196 Thousand USD | 126830.102% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2669.748% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2439.266% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2478.095% |
| HilleVax, Inc. | -2.15 Million USD | 11620.918% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 256173.196% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1655598.534% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 37284.281% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1080060.87% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3309262.075% |
| Savara Inc. | -44.26 Million USD | 661.183% |
| Curis, Inc. | 9.81 Million USD | -2431.76% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8868.732% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 199150.389% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 14466.165% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 109043.421% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.052% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 8984.116% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 162.15% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -338.172% |
| Erasca, Inc. | -3.73 Million USD | 6755.707% |
| bluebird bio, Inc. | -4.03 Million USD | 6263.548% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 880357.283% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 86.957% |
| DBV Technologies S.A. | 15.72 Million USD | -1479.292% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 880357.283% |
| Moderna, Inc. | 2.15 Billion USD | 88.474% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 27246.557% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3002.561% |
| Molecular Templates, Inc. | 50.39 Million USD | -392.888% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 46441.604% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -85.66% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 4092.141% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 731.347% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 323.518% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 7022.826% |
| MacroGenics, Inc. | 50.52 Million USD | -391.601% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 4173.319% |
| Prime Medicine, Inc. | -147.9 Million USD | 267.94% |
| Aditxt, Inc. | -111.66 Thousand USD | 222552.982% |
| Adagene Inc. | 18.11 Million USD | -1271.455% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -50799.795% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -77.167% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -57.373% |
| SciSparc Ltd. | 2.19 Million USD | -11211.066% |
| Vericel Corporation | 135.57 Million USD | -83.212% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 991720.424% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 801826.809% |
| Generation Bio Co. | -73.91 Million USD | 436.068% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 56940.046% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -354.77% |
| Invivyd, Inc. | -2.02 Million USD | 12348.077% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 182.566% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 240235.153% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -157.753% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -152.718% |
| ADMA Biologics, Inc. | 88.21 Million USD | -181.565% |
| Clene Inc. | 533 Thousand USD | -46502.439% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -930.275% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 26055.172% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1298.754% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -12394.517% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 127928.383% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -398.727% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3602.411% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 29811.842% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -197.777% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -339640.398% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -367.234% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 243.423% |
| Trevena, Inc. | 1.45 Million USD | -16971.546% |
| Surrozen, Inc. | -27.23 Million USD | 1012.196% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 70465.722% |
| Cingulate Inc. | -582.91 Thousand USD | 42711.654% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 801361.29% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1360.932% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3281354.954% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 28294.211% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 63.51% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 25240.789% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 440962.944% |
| Kronos Bio, Inc. | 1.37 Million USD | -18004.3% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 562.846% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 85165.411% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 50967.065% |
| ImmunityBio, Inc. | -17.89 Million USD | 1488.435% |
| Korro Bio, Inc. | -3.63 Million USD | 6942.727% |
| Kineta, Inc. | 5.43 Million USD | -4471.894% |
| BioVie Inc. | -229.37 Thousand USD | 108389.41% |
| Codexis, Inc. | 57.33 Million USD | -333.235% |
| Celularity Inc. | 6.75 Million USD | -3577.143% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -6089.659% |
| Celcuity Inc. | -142.77 Thousand USD | 174077.391% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -490888.338% |
| Cibus, Inc. | 1.42 Million USD | -17367.722% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 66514.706% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1183.778% |
| IN8bio, Inc. | -2.5 Million USD | 10031.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1057.301% |
| Annexon, Inc. | -3.26 Million USD | 7703.03% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 12252.202% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 695.134% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -38711.094% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 68.094% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -43.616% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 13173.211% |
| Arcellx, Inc. | 108.27 Million USD | -129.399% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 867.373% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -213.609% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1274.314% |
| Moolec Science SA | -143.3 Thousand USD | 173430.309% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 686.963% |
| Geron Corporation | -123.5 Million USD | 301.121% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7456.769% |
| Royalty Pharma plc | 1.79 Billion USD | 86.154% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 454.389% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6876927.243% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -107246.872% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 322.944% |
| Humacyte, Inc. | -76.55 Million USD | 424.482% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 26269.174% |
| 89bio, Inc. | -273 Thousand USD | 91085.714% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19860.621% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 29391.392% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 202043.902% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -22097.587% |
| Notable Labs, Ltd. | 113 Thousand USD | -219715.044% |
| Liquidia Corporation | 14.6 Million USD | -1601.308% |
| Mustang Bio, Inc. | -2.22 Million USD | 11263.64% |
| Immunovant, Inc. | -231 Thousand USD | 107628.571% |
| Quantum-Si incorporated | 488 Thousand USD | -50799.795% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 547.076% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 828070.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -13240.011% |
| Acasti Pharma Inc. | -11 Thousand USD | 2258200.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 121493.139% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 38405.107% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 248.283% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21792.771% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 65294.488% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12785.955% |
| PepGen Inc. | -1.18 Million USD | 21078.97% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 195683.465% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.0% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1184.819% |
| Solid Biosciences Inc. | -76.56 Million USD | 424.427% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 300877.4% |
| Immuneering Corporation | -764.13 Thousand USD | 32606.039% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -374750.598% |
| Belite Bio, Inc | -399 Thousand USD | 62353.383% |
| XOMA Corporation | 3.86 Million USD | -6333.333% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1339.723% |
| Bionomics Limited | -434.44 Thousand USD | 57273.799% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 23227.654% |
| uniQure N.V. | 2.21 Million USD | -11114.041% |
| Cassava Sciences, Inc. | -89.42 Million USD | 377.771% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 369.788% |
| Forte Biosciences, Inc. | -9000.00 USD | 2760000.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 29847.425% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 56940.046% |
| Altimmune, Inc. | -65.37 Million USD | 479.96% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 31.389% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 23227.654% |
| Compugen Ltd. | 31.45 Million USD | -689.671% |
| Peak Bio, Inc. | 367.76 Thousand USD | -67439.95% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -913.179% |
| Benitec Biopharma Inc. | 108 Thousand USD | -229891.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 318550.0% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20747.631% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 13732.876% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 208831.933% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20747.631% |
| Instil Bio, Inc. | -4.75 Million USD | 5322.687% |
| argenx SE | 1.1 Billion USD | 77.592% |
| Immunome, Inc. | -8.9 Million USD | 2888.717% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 13242.381% |
| Verona Pharma plc | -679.62 Thousand USD | 36648.297% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 142037.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10514.717% |
| CervoMed Inc. | -1.29 Million USD | 19301.13% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10419.526% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5299.728% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9952.246% |
| Moolec Science SA | -143.3 Thousand USD | 173430.309% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 60975.671% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9397.713% |
| AnaptysBio, Inc. | 14.78 Million USD | -1580.475% |
| Design Therapeutics, Inc. | -537 Thousand USD | 46355.307% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 58271.194% |
| NeurAxis, Inc. | 2.15 Million USD | -11417.158% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11474.604% |
| Lumos Pharma, Inc. | 2 Million USD | -12276.233% |
| Achilles Therapeutics plc | -4.73 Million USD | 5349.989% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 142037.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 235151.81% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -684.589% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -28712.152% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 24168.895% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 645.339% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -577553.488% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 30317.883% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1887856.498% |
| Palisade Bio, Inc. | 246 Thousand USD | -100871.951% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 752800.0% |
| Beam Therapeutics Inc. | -59.67 Million USD | 516.261% |
| Neurogene Inc. | -3.26 Million USD | 7714.684% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -78.269% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6827.817% |
| Sesen Bio, Inc. | 40 Million USD | -520.978% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 83733.333% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6268.083% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2696.603% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1664.141% |
| Athira Pharma, Inc. | -969 Thousand USD | 25733.746% |
| Vaccinex, Inc. | -16 Million USD | 1652.056% |
| HCW Biologics Inc. | -574.82 Thousand USD | 43311.661% |
| XOMA Corporation | 3.86 Million USD | -6333.333% |
| Nektar Therapeutics | 53.47 Million USD | -364.473% |
| Arvinas, Inc. | 71.8 Million USD | -245.948% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 397.613% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 495.685% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 77240.062% |
| Rezolute, Inc. | -36 Thousand USD | 690075.0% |
| Clene Inc. | 533 Thousand USD | -46502.439% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 19345193.458% |
| BeyondSpring Inc. | 1.75 Million USD | -14085.665% |
| Synlogic, Inc. | -1.92 Million USD | 13010.135% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 671427.027% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 4022.789% |
| Peak Bio, Inc. | 367.76 Thousand USD | -67439.95% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1409.872% |
| Krystal Biotech, Inc. | 47.6 Million USD | -421.775% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -76.05% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4843.104% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9693.279% |
| MannKind Corporation | 136.19 Million USD | -82.384% |
| Ikena Oncology, Inc. | -50.49 Million USD | 591.941% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -128.271% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5764.561% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 98667.857% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4967920.0% |
| Legend Biotech Corporation | 140.92 Million USD | -76.253% |
| Mural Oncology plc | -2.56 Million USD | 9776.315% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 45180.036% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 248491.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1096.834% |
| REGENXBIO Inc. | 53.02 Million USD | -368.406% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4736.796% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 129218.129% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 14441.282% |
| Vaxart, Inc. | -60.76 Million USD | 508.787% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 94624.317% |
| Cellectis S.A. | 18 Thousand USD | -1379850.0% |
| Longeveron Inc. | 221 Thousand USD | -112294.118% |
| Repare Therapeutics Inc. | -80.07 Million USD | 410.217% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 77.274% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 19295.595% |
| Revolution Medicines, Inc. | -399.66 Million USD | 162.15% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 709788.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -506820.408% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.114% |
| Denali Therapeutics Inc. | -93.34 Million USD | 366.1% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 991720.424% |
| Veru Inc. | 7.56 Million USD | -3183.021% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 164597.351% |
| Cingulate Inc. | -582.91 Thousand USD | 42711.654% |
| Passage Bio, Inc. | -3.72 Million USD | 6775.383% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2062463.002% |
| Exicure, Inc. | -1.42 Million USD | 17555.446% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 64954.047% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -9089.456% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 48549.993% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -264.605% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 166128.996% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 519.537% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -63427.11% |
| OmniAb, Inc. | 14.66 Million USD | -1593.537% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1142.39% |
| Lipocine Inc. | -2.85 Million USD | 8812.973% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13577.537% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4453.918% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16590.24% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -229.798% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 382240.0% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -194.665% |
| Ocugen, Inc. | -33.53 Million USD | 840.648% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7955.503% |
| Q32 Bio Inc. | 578 Thousand USD | -42874.221% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 93832.453% |
| Alumis Inc. Common Stock | -1.28 Million USD | 19445.093% |
| Equillium, Inc. | 35.95 Million USD | -590.781% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14651.318% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -49510.828% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 6008590.566% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 96003.861% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -58661.284% |
| Dominari Holdings Inc. | 2.03 Million USD | -12082.001% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 135484.339% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1927.076% |
| Bio-Techne Corporation | 773.07 Million USD | 67.87% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1334.211% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 46.094% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 21348.161% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1135.826% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2023.544% |
| Nkarta, Inc. | -5.86 Million USD | 4332.254% |
| BioCardia, Inc. | -7.24 Million USD | 3526.555% |
| Iterum Therapeutics plc | -1.75 Million USD | 14293.771% |